What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
His primary scientific interests are in Cancer research, Lung cancer, Tumor suppressor gene, Molecular biology and Cancer.
John D. Minna interconnects DNA methylation, Carcinogenesis, Gene, Mutation and Loss of heterozygosity in the investigation of issues within Cancer research.
His Lung cancer research is included under the broader classification of Pathology.
John D. Minna has researched Tumor suppressor gene in several fields, including Breast cancer, Angiogenesis, Epigenetics and PTEN.
His Molecular biology study also includes
- Gene expression which is related to area like Transfection,
- Cell culture that connect with fields like Cell and Chemically defined medium.
His Cancer research includes themes of Immunology and Oncology.
His most cited work include:
- Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma (4000 citations)
- Evaluation of a Tetrazolium-based Semiautomated Colorimetric Assay: Assessment of Chemosensitivity Testing (3486 citations)
- Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers (1884 citations)
What are the main themes of his work throughout his whole career to date?
John D. Minna spends much of his time researching Cancer research, Lung cancer, Cancer, Molecular biology and Internal medicine.
John D. Minna has researched Cancer research in several fields, including Cell, Cell culture, Carcinogenesis, Tumor suppressor gene and KRAS.
The concepts of his Tumor suppressor gene study are interwoven with issues in DNA methylation and Loss of heterozygosity.
His Lung cancer study necessitates a more in-depth grasp of Pathology.
His work carried out in the field of Molecular biology brings together such families of science as Gene expression, Gene and Cell growth.
His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology.
He most often published in these fields:
- Cancer research (50.51%)
- Lung cancer (44.05%)
- Cancer (23.04%)
What were the highlights of his more recent work (between 2015-2021)?
- Cancer research (50.51%)
- Lung cancer (44.05%)
- Cancer (23.04%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer research, Lung cancer, Cancer, KRAS and Cancer cell.
His research investigates the link between Cancer research and topics such as Cell culture that cross with problems in Gene expression.
His Lung cancer research integrates issues from Computational biology and Adenocarcinoma.
His Cancer study typically links adjacent topics like Growth inhibition.
His KRAS research incorporates themes from Molecular biology, Mutant, Gene knockdown and MAPK/ERK pathway.
As a part of the same scientific study, John D. Minna usually deals with the Cancer cell, concentrating on Cell biology and frequently concerns with Microvesicles.
Between 2015 and 2021, his most popular works were:
- Small-cell lung cancer: what we know, what we need to know and the path forward (250 citations)
- Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. (169 citations)
- ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs. (150 citations)
In his most recent research, the most cited papers focused on:
John D. Minna focuses on Cancer research, Lung cancer, Cancer, Cancer cell and Adenocarcinoma.
His Cancer research study combines topics from a wide range of disciplines, such as Cell growth, NEUROD1, ASCL1, Oncogene and KRAS.
His study in Oncogene is interdisciplinary in nature, drawing from both Molecular biology and Cell culture.
His Molecular biology research is multidisciplinary, relying on both Mutation and EZH2.
His work deals with themes such as Epithelial–mesenchymal transition, Immunology and Bioinformatics, which intersect with Lung cancer.
His Cancer study incorporates themes from Growth inhibition, Telomerase, In vivo and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
